Personalised medicine: Finding a place in the pharmacodiagnostics revolution
This article was originally published in Clinica
Executive Summary
The rise of the pharmacodiagnostics industry is set to change the focus of the pharmaceutical industry dramatically. UK company, DxS is among the companies seeking to exploit this growing market, as CEO Steve Little told Claire Thomas